Venture-Backed Startups

0 investors

Biosortia is a drug discovery company whose Industrial-Scale Microbiome Mining (ISMM) platform extracts community-derived small molecules from the microbiome at kilogram-to-ton scale, using an AI tool (BiosortAI) to prioritize evolutionarily shaped compounds. Its lead program targets obesity and metabolic disease, with expansion into IBD, gut-brain neuromodulation, oncology, pain, and anti-infectives.

1 investor

Bios Partners is a venture capital firm focused on life sciences and biotech investments, providing diligence and portfolio support for clinical-stage and precision medicine companies. The firm combines deep expertise in drug development, pharmaceutical R&D, and equity research for healthcare institutions.

1 investor

Biospatial operates a data analytics platform that ingests emergency medical services (EMS) and health data to deliver real-time analytics and insights for healthcare and public health users. The company applies machine learning, anomaly detection, and multi-source data analytics to support clinical and biosurveillance workflows.

5 investors

Biospectal develops OptiBP, a smartphone app that measures and tracks blood pressure using a fingertip on the phone's camera, allowing users to record BP history and share it with doctors. The app is CE-MDR EU Class IIa certified and targets people managing hypertension and heart health.

1 investor

BioSpeedia is a biotechnology company that develops and produces rapid lateral-flow diagnostic tests for infectious diseases, including tests for bacterial meningitis and SARS-CoV-2. A spin-off from the Institut Pasteur, it distributes its diagnostic products worldwide through affiliated entities.

1 investor

Biosphere develops a modern, UV-enabled bioreactor designed to lower the capital intensity of biomanufacturing, replacing legacy steam-based bioreactor designs. Its technology targets industrial biology applications such as therapeutics, enzymes, proteins, bioplastics, fertilizers, and jet fuel.

2 investors

Biospring is an investment firm that partners with technology-enabled, EBITDA-positive pharma services businesses focused on manufacturing and clinical trial services. Its portfolio companies produce and support the supply chain for complex medicines such as biologics, cell therapies, and peptides, and modernize clinical trial site operations, patient recruitment, and related technology for the life sciences industry.

1 investor

BioSqueeze develops well integrity solutions for the oil and gas industry, using biomineralization technology to seal cement gaps and leaks in wells. The company offers multiple sealing products (MicroSeal, MacroSeal, NanoSeal) and diagnostic services for well remediation and decommissioning.

2 investors

Cardiovascular device company developing HAART aortic valve repair technologies as an alternative to valve replacement. Assets acquired by Corcym in 2023.

1 investor

BioStack provides a platform for bioinformatics and experimental science that integrates biological insights with computational technology. The platform serves researchers and scientists working in modern biology and life sciences research.

3 investors

Biostate AI is a biotech company that develops AI-driven solutions for the life sciences and medical research sectors. The company operates multiple international subsidiaries and partnerships focused on advancing genomics and health diagnostics.

3 investors

0 investors

BioStem Technologies develops, manufactures, and commercializes perinatal tissue-based allografts for regenerative therapies, using its proprietary BioRetain processing method to preserve the tissue's biological properties. Products are made in an AATB-accredited, FDA-registered, cGMP-compliant lab and serve the regenerative medicine market.

0 investors

BioStream Technologies makes LOOKWARE, a digital adjunctive training platform that uses gaze-contingent eye-tracking and a gaming interface to deliver ABA-based social skills training for children on the autism spectrum. It is used by ABA therapists, autism service providers, and special education teachers and schools to complement therapy and individualized education programs.

0 investors

0 investors

BioSurfaces develops medical devices, 3D tissue engineering scaffolds, and personal care products using its proprietary Bio-Spun nanofiber technology. The company works in the medical device and tissue engineering space, with collaborations that include Takeda, NIH, and Corning.

0 investors

Biosurfit develops point-of-care diagnostic technology that produces lab-quality results from a single finger-prick blood sample. Its disposable disc platform can combine immunoassays, haematology, and clinical chemistry analytes in one test to support physicians' diagnostic and treatment decisions.

1 investor

BioSurplus buys, sells, sources, redeploys, and auctions used life-science laboratory equipment, helping companies recover capital from idle assets and helping buyers access quality instruments. It serves life-science companies and researchers in the secondary market for lab equipment.

1 investor

0 investors

Biosynthetic Technologies manufactures biobased synthetic base oils called Estolides, derived from organic fatty acids in bio-derived oils, that serve as drop-in replacements for conventional lubricant base oils. Its products target industrial lubricants, metalworking fluids, grease, food grade applications, and personal care/beauty ingredients.

1 investor

BioT provides cloud infrastructure for medical device companies to connect devices, manage clinical data, and deliver connected care, with built-in security and regulatory compliance (FDA, HIPAA, GDPR, MDR). Its no-code/low-code platform lets device makers add cloud services, build custom modules, and integrate with EHRs, CRMs, and third-party systems.

3 investors

0 investors

1 investor